- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem, page-114
-
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
93.8¢ |
Change
-0.003(0.27%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
94.0¢ | 94.0¢ | 92.0¢ | $559.4K | 600.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 16543 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.0¢ | 35916 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 56373 | 0.930 |
12 | 43611 | 0.925 |
14 | 136452 | 0.920 |
15 | 341145 | 0.915 |
16 | 793366 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 8845 | 4 |
0.940 | 44827 | 9 |
0.945 | 57316 | 9 |
0.950 | 130250 | 11 |
0.955 | 117986 | 7 |
Last trade - 10.30am 03/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online